Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News InnovAge Holding Corp INNV

Healthcare Drug Manufacturers - Major
InnovAge Holding Corp. is a healthcare delivery platform. The Company is focused on providing all-inclusive, capitated care to high-cost, dual-eligible seniors. The Company's programs are designed to allow frail seniors to live life on their terms by aging in place, in their own homes and communities, for as long as safely possible. Through its Program of All-Inclusive Care for the Elderly... see more

Recent & Breaking News (NDAQ:INNV)

Innovus Pharmaceuticals Strengthens Its Intellectual Property Portfolio with New Patent for Its Sensum+® Product in Mexico

Business Wire November 16, 2017

Innovus Pharmaceuticals Reports Nine Month Net Revenue of $6.4 million and Net Loss Decrease of 51.6% Compared to the Same Period in 2016

Business Wire November 14, 2017

Innovus Pharma Launches FlutiCare™ OTC Nasal Spray Allergy Relief in the U.S.

Business Wire November 14, 2017

Innovus Pharma Enters the $11 Billion Glucose Monitoring Market with FDA-Cleared Products via an Expanded Agreement with ACON Laboratories, Inc.

Business Wire November 13, 2017

Innovus Pharma Announces Agreement with ACON Laboratories, Inc.

Business Wire November 9, 2017

Innovus Pharmaceuticals to Release Third Quarter 2017 Financial Results and Provide Corporate Update on Tuesday, November 14, 2017

Business Wire November 6, 2017

Innovus Pharma to Exhibit at 2017 American Society of Reproductive Medicine (“ASRM”) Scientific Congress and Expo in San Antonio, Texas

Business Wire October 24, 2017

Innovus Pharma Receives Approval from Health Canada for Vesele as a Natural Health Product

Business Wire October 18, 2017

Innovus Pharmaceuticals Expands Its International Proprietary Product Patent Portfolio with Its First Chinese Patent

Business Wire October 11, 2017

Innovus Pharma Announces the Availability of the Full Label for its Nasal Drug FlutiCare™ for Allergy Symptom Relief on DailyMed

Business Wire September 27, 2017

Innovus Pharma’s Partner Luminarie Receives Approval for Zestra® for Female Sexual Arousal Disorder as a Medical Device I from New Zealand’s Medicines and Medical Devices Safety Authority

Business Wire September 20, 2017

Innovus Pharma Announces the Launch of Zestra® in France, Belgium and Monaco by Its Partner, Densmore

Business Wire September 19, 2017

Innovus Pharma Receives Approval from Health Canada for its UriVarx™ Product for the Indication to Reduce Symptoms of Overactive Bladder such as Daytime Urinary Frequency, Urgency and Nocturia

Business Wire September 6, 2017

Innovus Pharma to Present at Rodman & Renshaw 19th Annual Global Investment Conference

Business Wire August 28, 2017

Innovus Pharma Files Product License Application for the Commercialization of Its Seasonal Allergic Rhinitis Product in Canada

Business Wire August 24, 2017

Innovus Pharma CEO Details FlutiCare Launch into Lucrative Market -- SECFilings.com

Marketwired August 18, 2017

Innovus Pharmaceuticals Reports a Quarterly Net Revenue Increase of 99.2% and Net Loss Decrease of 74.1% Compared to the Same Period in 2016

Business Wire August 14, 2017

Innovus Pharma Orders its First Commercial Batch of 220,000 Units of FlutiCare™

Business Wire August 9, 2017

Innovus Pharmaceuticals to Release Second Quarter 2017 Financial Results and Provide Corporate Update on Monday, August 14, 2017

Business Wire August 2, 2017

Innovus Pharma Files its Product License Application in Canada for the Commercialization of its Drug Xyralid™

Business Wire July 31, 2017